Chemistry: analytical and immunological testing – Involving production or treatment of antibody
Reexamination Certificate
2006-10-16
2009-11-10
Saoud, Christine J (Department: 1649)
Chemistry: analytical and immunological testing
Involving production or treatment of antibody
C436S548000, C424S141100, C424S142100
Reexamination Certificate
active
07615383
ABSTRACT:
The invention concerns agonist anti-trkC monoclonal antibodies which mimic certain biological activities of NT-3, the native ligand of trkC. The invention further concerns the use of such antibodies in the prevention and/or treatment of cellular degeneration, including nerve cell damage associated with acute nervous cell system injury and chronic neurodegenerative diseases, including peripheral neuropathy.
REFERENCES:
patent: 5364769 (1994-11-01), Rosenthal
patent: 5766863 (1998-06-01), Godowski et al.
patent: 5891650 (1999-04-01), Godowski et al.
patent: 5910574 (1999-06-01), Presta et al.
patent: 6015552 (2000-01-01), Watanabe et al.
patent: 6656465 (2003-12-01), Clary et al.
patent: 2004/0137513 (2004-07-01), Devaux et al.
patent: 2007/0036794 (2007-02-01), Devaux et al.
patent: 455460 (1991-11-01), None
patent: 522530 (1993-01-01), None
patent: WO 97/21732 (1997-06-01), None
patent: WO 98/49308 (1998-11-01), None
patent: WO 00/24415 (2000-05-01), None
White et al. Nat Rev. Drug discovery. 2005. 4: 834-844.
Wang et al. Adv. Drug Delivery Rev. 2003. 55:949-965.
Wu et al. J. Mol. Biol. (1999) 294, 151-162.
MacCallum et al. J. Mol. Biol. 1996. 262, 732-745.
Burgess et al. J of Cell Bio. 111:2129-2138, 1990.
Bowie et al. Science, 1990, 247:1306-1310.
Rudikoff et al. Proc. Natl. Acad. Sci. USA 1982 vol. 79: p. 1979.
Pawson et al. 2003, Science 300:445-452.
Barbacid,J. Neurobiol. 25:1386-1403 [1994].
Barbarcid,Ann. New York Acad. Sci. 766:442-458 [1995].
Barde, Y.A. et al.,EMBO J. 1, 549-553 [1982].
Barker, PA,Cell Death Diff. 5:346-356 [1998].
Belliveau et al.,J. Cell. Biol. 136:375-388 [1997].
Berkemeir, et al.,Somat. Cell Mol. Genet. 18(3):233-245 [1992].
Berkemeir, L.R. et al.,Neuron 7, 857-866 [1991].
Capon et al.,Nature337: 525-531 [1989].
Casaccia-Bonnefil, et al.,Cell Death Diff. 5:357-364 [1998].
Carter et al.,Bio/Technology10: 163-167 [1992].
Chaudhry, et al.,Muscle and Nerve 23: 189-192 [2000].
Davies et al. (Neuron 11, 565-574 [1993].
Davies, AM,Curr. Biol. 10:R198-R200 [2000].
Donovan et al.,A.J. Path. 147:309-324 [1995].
Donovan et al.,Nature Genetics 14:210-213 [1996].
Ernfors et al.,Proc. Natl. Acad. Sci. USA 87, 5454-5458 (1990).
Farinas et al.,Neuron 21:325-334 [1998].
Gao et al.,Ann. Neurol. 38(1):30-7 [1995].
Gotz et al.,Nature 372:266-269 [1994].
Haase et al.,J. Neurol. Sci. 160:S97-S105 [1998].
Hallbook, F. et al.,Neuron 6, 845-858 [1991].
Hapner, et al.,Developm. Biol. 201:90-100 [1998].
Helgren et al.,J. Neurosci, 17(1):372-82 [1997].
Henzel et al.,J. Chromatography404: 41-52 [1987].
Herrmann et al.,Mol. Biol. Cell 4, 1205-1216 [1993].
Höhn et al.,Nature 344, 339 [1990].
Hongo et al.,Hybridoma14: 253-260 [1995].
Ip et al.,Proc. Natl. Acad. Sci USA 89, 3060-3064 [1992].
Jones and Reichardt,Proc. Natl. Acad. Sci. USA 87, 8060-8064 (1990).
Kabat and Wu,J. Immunol. 147: 1709-1719 [1991].
Kaisho et al.,FEBS Lett. 266, 187 [1990].
Klein et al.,EMBO J, 8, 3701-3709 [1989].
Kraemer et al.,Arteriol. Thromb. and Vasc. Biol. 19:1041-1050 [1999].
Lai, et al.,Mol. Cell. Neurosci. 11(1-2):64-76 [1998].
Lamballe et al.,Cell 66, 967-979 [1991].
Leibrock, J. et al.Nature 341, 149-152 [1989].
Levi-Montalcini, R. et al, P.U.,Physiol. Rev. 48, 534-569 [1968].
Maisonpierre et al.,Science 247, 1446 [1990].
Martin-Zanca et al.,Mol. Cell. Biol. 9(1):24-33 [1989].
Matsudaira,J. Biol. Chem. 262: 10035-10038 [1987].
Meakin and Shooter,Trends Neurosci. 15, 323-331 [1992].
Middlemas et al.,Mol. Cell. Biol. 11, 143-153 [1991].
Nilsson et al.,FEBS Letters 424(3):285-90 [1998].
Raoul et al.,Curr. Op. Neurobiol. 10:111-117 [2000].
Rodriguez-Tebar et al.,EMBO J. 11, 917-922 [1992].
Rosenthal et al.,Neuron 4, 767 [1990].
Ryden and Ibanez,J. Biol. Chem. 271:5623-5627 [1996].
Sadick et al.,Exp. Cell Res. 234: 354-361 [1997].
Shelton et al.,J. Neurosci. 15: 477-491 [1995].
Thoenen, H. et al.,Rev. Physiol. Biochem. Pharmacol. 109, 145-178 [1987].
Tsoulfas et al.,Neuron10:975-990 [1993].
Ultsch et al.,J. Mol. Biol. 290:149-159 (1999).
Urfer et al.,Biochem. 36:4775-4781 [1997].
Urfer et al.,EMBO J. 14:2795-2805 [1995].
Berkower, I., “The Promise and Pitfalls of Monoclonal Antibody Therapeutics,”Curr. Opi. Biotech., 7: 622-628, 1996.
Hongo, J. et al. “Agonist Monoclonal Antibodies to Human trkC Receptor map to Epitopes Overlapping with NT-3 Binding Site,”Society for Neuroscience Abstracts, 27(1), 2001.
Mendez, M., et al., “Functional Transplant of Megabase Human Immunoglobulin Loci Recapitulates Human Antibody Response in Mice,”Nature Genetics, 15(2): 146-156, 1997.
Peterson, N., et al., “Bacterial Expression and Characterization of Recombinant Biologically Active Anti-Tyrosine Kinase Receptor Antibody Forms,” DNA and Cell Biol., 17: 1031-1040, 1998.
Urfer, R., et al., “High Resolution Mapping of the Binding Site of TrkA for Nerve Growth Factor and TrkC for Neurotrophin-3 on the second Immunologlobulin-like domain on the Trk Receptors,”The Journal of Biological Chemistry, 273(10): 5829-5840, 1998.
Devaux Brigitte
Hongo Jo-Anne
Presta Leonard G.
Shelton David L.
Dreger Ginger R.
Elliott Jennifer L.
Fox James A.
Genentech Inc.
Saoud Christine J
LandOfFree
Methods for treating neuropathy by agonist anti-trk-C... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating neuropathy by agonist anti-trk-C..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating neuropathy by agonist anti-trk-C... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4126351